| ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study R Caorsi, F Penco, A Grossi, A Insalaco, A Omenetti, M Alessio, G Conti, ... Annals of the rheumatic diseases 76 (10), 1648-1656, 2017 | 244 | 2017 |
| Differentiating PFAPA syndrome from monogenic periodic fevers M Gattorno, R Caorsi, A Meini, M Cattalini, S Federici, F Zulian, E Cortis, ... Pediatrics 124 (4), e721-e728, 2009 | 209 | 2009 |
| Type I interferon-mediated autoinflammation due to DNase II deficiency MP Rodero, A Tesser, E Bartok, GI Rice, E Della Mina, M Depp, B Beitz, ... Nature communications 8 (1), 2176, 2017 | 204 | 2017 |
| Clinical presentation and pathogenesis of cold‐induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation S Borghini, S Tassi, S Chiesa, F Caroli, S Carta, R Caorsi, M Fiore, ... Arthritis & Rheumatism 63 (3), 830-839, 2011 | 194 | 2011 |
| Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease E Pontali, S Volpi, G Antonucci, M Castellaneta, D Buzzi, F Tricerri, ... Journal of Allergy and Clinical Immunology 146 (1), 213-215, 2020 | 148 | 2020 |
| Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1β secretion S Tassi, S Carta, L Delfino, R Caorsi, A Martini, M Gattorno, A Rubartelli Proceedings of the National Academy of Sciences 107 (21), 9789-9794, 2010 | 143 | 2010 |
| Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra L Lepore, G Paloni, R Caorsi, M Alessio, D Rigante, N Ruperto, ... The Journal of pediatrics 157 (2), 310-315. e1, 2010 | 135 | 2010 |
| Type I interferonopathies in pediatric rheumatology S Volpi, P Picco, R Caorsi, F Candotti, M Gattorno Pediatric Rheumatology 14, 1-12, 2016 | 132 | 2016 |
| Monogenic polyarteritis: the lesson of ADA2 deficiency R Caorsi, F Penco, F Schena, M Gattorno Pediatric Rheumatology 14, 1-16, 2016 | 127 | 2016 |
| Diagnosis and management of autoinflammatory diseases in childhood M Gattorno, S Federici, MA Pelagatti, R Caorsi, G Brisca, C Malattia, ... Journal of Clinical Immunology 28, 73-83, 2008 | 127 | 2008 |
| Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A gene MA Pelagatti, A Meini, R Caorsi, M Cattalini, S Federici, F Zulian, ... Arthritis & Rheumatism 63 (4), 1141-1150, 2011 | 119 | 2011 |
| T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency I Brigida, M Zoccolillo, MP Cicalese, L Pfajfer, F Barzaghi, S Scala, ... Blood, The Journal of the American Society of Hematology 132 (22), 2362-2374, 2018 | 111 | 2018 |
| Type I interferon pathway activation in COPA syndrome S Volpi, J Tsui, M Mariani, C Pastorino, R Caorsi, O Sacco, A Ravelli, ... Clinical Immunology 187, 33-36, 2018 | 104 | 2018 |
| A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency S Volpi, MP Cicalese, P Tuijnenburg, ATJ Tool, E Cuadrado, ... Journal of Allergy and Clinical Immunology 143 (6), 2296-2299, 2019 | 91 | 2019 |
| Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a … M Cattalini, S Della Paolera, F Zunica, C Bracaglia, M Giangreco, ... Pediatric Rheumatology 19, 1-11, 2021 | 89 | 2021 |
| Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome S Volpi, A Insalaco, R Caorsi, E Santori, V Messia, O Sacco, ... Journal of clinical immunology 39, 476-485, 2019 | 89 | 2019 |
| The autoinflammatory diseases S Federici, R Caorsi, M Gattorno Swiss medical weekly 142 (2526), w13602-w13602, 2012 | 88 | 2012 |
| Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia E Pontali, S Volpi, A Signori, G Antonucci, M Castellaneta, D Buzzi, ... Journal of Allergy and Clinical Immunology 147 (4), 1217-1225, 2021 | 87 | 2021 |
| Biologic drugs in autoinflammatory syndromes R Caorsi, S Federici, M Gattorno Autoimmunity reviews 12 (1), 81-86, 2012 | 85 | 2012 |
| The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age R Caorsi, L Lepore, F Zulian, M Alessio, A Stabile, A Insalaco, M Finetti, ... Arthritis research & therapy 15, 1-8, 2013 | 84 | 2013 |
